3.63
price down icon2.68%   -0.10
after-market Dopo l'orario di chiusura: 3.60 -0.03 -0.83%
loading

Sonnet Biotherapeutics Holdings Inc Borsa (SONN) Ultime notizie

pulisher
01:51 AM

Why Sonnet BioTherapeutics Holdings Inc. stock is a value investor pickJuly 2025 Institutional & High Accuracy Trade Signal Alerts - Trung tâm Dự báo KTTV quốc gia

01:51 AM
pulisher
01:41 AM

Published on: 2025-10-17 12:41:30 - newser.com

01:41 AM
pulisher
01:27 AM

What sentiment indicators say about Sonnet BioTherapeutics Holdings Inc. stockWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com

01:27 AM
pulisher
12:08 PM

What recovery options are there for Sonnet BioTherapeutics Holdings Inc.Weekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com

12:08 PM
pulisher
11:51 AM

Applying big data sentiment scoring on Sonnet BioTherapeutics Holdings Inc.Risk Management & Weekly Setup with ROI Potential - newser.com

11:51 AM
pulisher
06:42 AM

Can Sonnet BioTherapeutics Holdings Inc. stock outperform in 2025 bull market - newser.com

06:42 AM
pulisher
04:47 AM

How Sonnet BioTherapeutics Holdings Inc. stock performs in rate cut cycles2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com

04:47 AM
pulisher
01:02 AM

How Sonnet BioTherapeutics Holdings Inc. stock reacts to global recession fearsJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

01:02 AM
pulisher
12:20 PM

Applying sector rotation models to Sonnet BioTherapeutics Holdings Inc.Dividend Hike & AI Driven Stock Price Forecasts - newser.com

12:20 PM
pulisher
Oct 16, 2025

Sonnet BioTherapeutics Holdings Inc Stock Analysis and ForecastTechnical Breakout Signals & Free Quantitative Trading Strategies - earlytimes.in

Oct 16, 2025
pulisher
Oct 15, 2025

Momentum divergence signals in Sonnet BioTherapeutics Holdings Inc. chart2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sonnet BioTherapeutics (SONN) Advances Cancer Research with Inno - GuruFocus

Oct 15, 2025
pulisher
Oct 15, 2025

Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma - The Manila Times

Oct 15, 2025
pulisher
Oct 13, 2025

Sonnet BioTherapeutics (NASDAQ:SONN) and CNS Pharmaceuticals (NASDAQ:CNSP) Head-To-Head Comparison - Defense World

Oct 13, 2025
pulisher
Oct 12, 2025

Is Sonnet BioTherapeutics Holdings Inc. stock ready for a breakoutTrade Volume Summary & Long-Term Growth Portfolio Plans - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will Sonnet BioTherapeutics Holdings Inc. stock go up soonJuly 2025 Decliners & Long-Term Growth Plans - newser.com

Oct 12, 2025
pulisher
Oct 06, 2025

Can Sonnet BioTherapeutics Holdings Inc. recover in the next quarterJuly 2025 Summary & Precise Trade Entry Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using economic indicators to assess Sonnet BioTherapeutics Holdings Inc. potential2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Historical volatility pattern of Sonnet BioTherapeutics Holdings Inc. visualized2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com

Oct 06, 2025
pulisher
Oct 03, 2025

Sonnet BioTherapeutics Holdings Inc. stock outlook for YEAR2025 Analyst Calls & Weekly High Momentum Picks - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can momentum traders help lift Sonnet BioTherapeutics Holdings Inc.Price Action & AI Driven Stock Movement Reports - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Sonnet BioTherapeutics (NASDAQ:SONN) Trading Down 8.3% – Should You Sell? - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Sonnet BioTherapeutics Approves Key Proposals at Meeting - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

What drives Sonnet BioTherapeutics Holdings Inc stock priceStraddle and Strangle Trades & Rapid Portfolio Trading - earlytimes.in

Sep 29, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):